Sporadic Incomplete, Genetic Insufficient: Framing Atypical BSE Origin Ahead of Canadian E211K Screening

by Ulofe Uduokhai

September 2025

The tension

WOAH treats atypical BSE as a spontaneous disease of older cattle, detected almost exclusively beyond eight years of age and unlinked to contaminated feed (WOAH Terrestrial Manual, Chapter 3.4.5). That framing has carried regulatory weight: atypical cases are excluded from classical BSE risk status calculations. It sits uneasily beside two independent H-type cases that carry a germline glutamic acid-to-lysine substitution at bovine PRNP codon 211.

The first was the 2006 Alabama H-BSE cow. Nicholson and colleagues (2008) showed that the animal and its only known offspring were both heterozygous GAA/AAA at codon 211, establishing that E211K is a heritable germline polymorphism rather than a one-off somatic event. The second is Canadian BSE case 20, the December 2021 Red Poll cow characterised by Tahir and colleagues (2025) at the National Centre for Animal Diseases. That animal was heterozygous E211K; identical sequence change in brainstem, retropharyngeal lymph node, tongue, and quadriceps confirmed germline status. None of Canada's prior nineteen BSE cases, including the 2006 H-type and 2007 L-type atypical cases, carried this mutation (Tahir et al., 2025).

The question is not whether a genetic pathway exists. It does. The question is whether the sporadic hypothesis remains intact as a population-level account, and what allele-frequency data would have to show before that account can be confirmed, refined, or limited.

Argument in brief

The either/or framing is the wrong one. Spontaneous atypical BSE remains the best account for most cases. Germline E211K is a real, heritable minority path with a human analogue in E200K and measurable effects on incubation under experimental challenge. What remains unknown is proportion: how much of the atypical caseload sits on each side of that partition, and whether undetected germline carriers exist at frequencies that disease surveillance cannot see. A herd screen is built to begin quantifying that proportion, provided germline and somatic signals are not confused.

Methods decide origin claims

Origin is not read from clinical signs. It is read from a diagnostic cascade that the WOAH Terrestrial Manual separates by purpose: rapid tests for surveillance throughput, immunohistochemistry and immunoblot for confirmation and strain typing, and, when genetics are at issue, multi-tissue PRNP sequencing.

ELISA and related enzyme immunoassays detect proteinase K-resistant PrPSc at high throughput. They do not distinguish C-, H-, and L-type. Case 20 entered the system as a Bio-Rad TeSeE non-negative under the fallen-stock stream; Prionics-Check PrioSTRIP and repeat ELISA at the reference laboratory sustained the suspect call. Confirmation required SAF immunoblot with 6H4. Strain typing required hybrid Western blot: C-terminal antibody 94B4 showed the unglycosylated band migrating higher than C-BSE and matching H-BSE controls; N-terminal antibody P4, which retains reactivity only when the proteinase K cleavage site leaves its epitope intact, labelled case 20 and the H-BSE control but not C- or L-type controls; a fourth band near 10 kDa, absent from C- and L-type, further aligned with H-type. Greater sensitivity to stringent proteinase K digestion relative to classical BSE closed the typing argument (Tahir et al., 2025).

Immunohistochemistry mapped tropism. PrPSc was abundant in CNS regions; peripheral involvement was absent or weak (occasional neuronal labelling in trigeminal ganglion and vagus). That distribution is consistent with prior atypical BSE and does not, by itself, speak to genetic versus spontaneous origin. What spoke to origin was DNA: the same E211K heterozygosity across multiple tissues. Biochemistry typed the strain; sequencing classified the etiology. Conflating the two is a common error. H-type banding does not imply E211K, and E211K cases still present as H-type on blot. Case 20 matched prior Canadian and reference H-BSE patterns.

Cassmann and colleagues (2023) used the same triad (EIA, anti-PrPSc IHC, Western blot) when they showed that EK211 and KK211 cattle develop intracranial H-BSE with shorter mean incubations (10.3 and 9.5 months) than EE211 cattle (17.6 months). The K211 allele accelerates disease once agent is present; it does not invent a new blot signature. Origin questions travel through genetics; strain questions travel through immunoblot and IHC.

Why E211K is rarely seen, and why that is ambiguous

After the US case, Heaton and colleagues (2008) screened 6,062 US cattle and detected no K211 allele, estimating an upper bound below one in two thousand. Parallel screens in China, Poland, Pakistan, and Korea were likewise negative for germline E211K (reviewed in Tahir et al., 2025). The allele appears vanishingly rare in sampled populations.

Rarity of detection is not the same as rarity of biological contribution. Classical BSE incidence peaked in animals roughly four to six years old (WOAH Terrestrial Manual, Chapter 3.4.5). Atypical cases are almost exclusively eight years or older: WOAH notes this as a common feature of atypical BSE, and Biacabe and colleagues (2008) found that all 13 French atypical cases identified in 2001-2007 were in cattle older than eight years. Beef production routinely removes animals at eighteen to twenty-four months, before the age window in which atypical disease declares itself. If E211K behaves like its human homologue, that truncation matters.

Human E200K is the same Glu-to-Lys substitution at the homologous surface-exposed position. Zhang and colleagues (2000) showed by NMR that the E200K backbone tertiary structure is nearly identical to wild-type; the major structural consequence they identify is perturbation of surface electrostatic potential, which they interpret as favoring altered interactions with membranes or auxiliary proteins rather than frank unfolding. Life-table analyses in Libyan Jewish kindreds by Chapman and colleagues (1994) and Spudich and colleagues (1995) gave age-dependent penetrance approaching 0.77 by seventy and 0.89 to 0.96 into the ninth decade. Prospective US follow-up after antemortem PRNP testing revises estimates downward (about 69% by eighty; median death around seventy-five; Minikel et al., 2025) without removing the core pattern: high penetrance, late onset. Vallabh and colleagues (2024) showed that CSF RT-QuIC can detect seeding activity in asymptomatic E200K carriers one to roughly three years before clinical onset, modulated by codon 129 genotype. Subclinical replication precedes disease.

Mapped onto cattle, the prediction is straightforward. Carriers slaughtered young will almost never appear in BSE surveillance, whatever the true allele frequency. Disease surveillance therefore underestimates genetic contribution; allele-frequency screening is the assay that can measure it. Cassmann's shortened incubations in K211 genotypes supply the bovine kinetic half of that analogy. They do not prove that every germline E211K allele will produce spontaneous H-BSE in the field. They show that when H-BSE agent is present, host genotype at 211 changes kinetics, consistent with a pathogenic polymorphism, not proof of universal penetrance under natural conditions.

The sporadic hypothesis is not optional

A purely genetic account fails on geography and genotype. Brazil has reported multiple atypical BSE cases over more than two decades of surveillance and has never recorded classical BSE (Alessi, 2013; Brazilian Ministry of Agriculture notices summarized through 2021). Sweden's H-type case, reported by Gavier-Widen and colleagues (2008), occurred in a twelve-year-old animal in a country without a classical epidemic; germline PRNP mutation was not supported. French active surveillance found atypical cases at roughly one to two per million cattle over eight years tested (Biacabe et al., 2008), without E211K as a shared explanation. Canada itself already illustrates dual pathways in one national herd: atypical cases without E211K, then case 20 with germline E211K (Tahir et al., 2025).

Spontaneous misfolding remains the best explanation for the majority of atypical cases. The genetic pathway does not replace it. It limits it.

The somatic complication

Won and colleagues (2020) reported high rates of K211 sequence in medulla oblongata only (approximately 10%, 28%, and 19.55% in three Holsteins), with blood and other brain regions negative. Kim and colleagues (2022) found no proteinase K-resistant PrP in those animals; highly sensitive amplification assays have also been reported negative (discussed in Tahir et al., 2025). The cattle were young. Whether medulla-restricted mosaicism can initiate H-BSE at some allele fraction, or with more time, is unresolved.

For a prevalence screen this is not a footnote. A blood-based assay that returns K211 could reflect germline heterozygosity (a true carrier, heritable to offspring) or, if brain tissue is the only positive compartment, a somatic mosaic of unknown pathogenic weight. Tahir and colleagues' (2025) multi-tissue confirmation for case 20 is therefore the interpretive standard any screen should adopt for putative positives: brainstem plus at least one non-CNS tissue before a result is scored as germline. A medulla-only signal is not a carrier call.

What a 1,000 to 1,200-cattle E211K screen can and cannot answer

If germline E211K is found at low frequency, the rare-genetic-subset model is supported: atypical BSE remains mostly spontaneous, with a measurable genetic minority. Breed and regional stratification (including Red Poll and related lines connected to case 20) become immediately actionable for follow-up.

If germline E211K is not found, the result is consistent with the Heaton upper bound and with vanishing rarity in prior international screens. It does not exclude the allele. At n of about 1,200, power is limited for frequencies near or below 1 in 2,000; a null tightens the Canadian bound without proving absence. Independent occurrence is also not ruled out by a population screen: Tahir and colleagues (2025) explicitly list spontaneous acquisition during early embryonic development among possible origins of E211K in case 20.

If K211 sequence appears in any sample, multi-tissue sequencing is required before interpretation. Concordant change across CNS and peripheral tissues supports germline carriage and inheritance risk. Medulla-restricted change recapitulates the Won pattern and cannot be equated with a breeding carrier or with proven disease risk, given Kim's negative PrPSc findings to date.

What the screen cannot do alone: quantify the fraction of historical atypical cases that were genetic; establish age-dependent penetrance of bovine E211K under natural exposure; resolve whether somatic K211 ever seeds disease; or, by itself, rewrite WOAH's sporadic framing. Those require longitudinally linked genotype-phenotype data, older animals, and continued case-by-case PRNP sequencing of every field BSE, work already embedded in reference-laboratory practice.

The Canadian 2021 case moved E211K from a US singularity to a repeated, geographically independent germline finding. The prevalence screen is the next measurement: not to decide whether atypical BSE is "really" genetic or "really" sporadic, but to begin estimating how much of each Canada is carrying, and to design the workflow so that germline and somatic signals are not confused.

Primary sources

  1. Tahir W, et al. (2025). Canadian 2021 H-type BSE case associated with a novel E211K polymorphism in prion protein gene. Prion 19:36-49.
  2. Nicholson EM, et al. (2008). Identification of a heritable polymorphism in bovine PRNP associated with genetic TSE. PLoS One 3:e2912.
  3. Heaton MP, et al. (2008). Prevalence of the prion protein gene E211K variant in U.S. cattle. BMC Vet Res 4:25.
  4. Cassmann ED, et al. (2023). Short incubation periods of atypical H-type BSE in cattle with EK211 and KK211 genotypes. Front Vet Sci 10:1301998.
  5. Zhang Y, et al. (2000). Solution structure of the E200K variant of human prion protein. J Biol Chem 275:33650-33654.
  6. Chapman J, et al. (1994). Risk of CJD in subjects with the PRNP codon 200 point mutation. Neurology 44:1683-1686.
  7. Spudich S, et al. (1995). Complete penetrance of CJD in Libyan Jews carrying the E200K mutation. Mol Med 1:607-613.
  8. Minikel EV, et al. (2025). Mortality of individuals with antemortem genetic testing for PRNP variants in the United States, 1998-2024. medRxiv.
  9. Vallabh SM, et al. (2024). Fluid biomarkers in individuals at risk for genetic prion disease up to disease conversion. Neurology 103:e209506.
  10. Won SY, et al. (2020). First report of potential BSE-related somatic mutation E211K in cattle. Int J Mol Sci 21:4246.
  11. Kim YC, et al. (2022). Absence of proteinase K-resistant PrP in Korean Holstein cattle carrying E211K somatic mutation. Transbound Emerg Dis.
  12. WOAH. Terrestrial Manual, Chapter 3.4.5 Bovine spongiform encephalopathy.
  13. Biacabe AG, et al. (2008). Atypical BSEs, France, 2001-2007. Emerg Infect Dis 14:298-300.
  14. Gavier-Widen D, et al. (2008). BSE in Sweden: an H-type variant. J Vet Diagn Invest.
  15. Alessi AC (2013). Atypical BSE in Brazil and worldwide. Brazilian Journal of Veterinary Pathology.